1-1 of 1
Authors: Melissa Marko
Journal Article
RANDOMIZED, DOUBLE-BLIND, PLACEBO (PBO)-CONTROLLED, SINGLE- AND MULTIPLE-DOSE PHASE 1 STUDY OF VE202, A DEFINED BACTERIAL CONSORTIUM FOR TREATMENT OF IBD: SAFETY AND COLONIZATION DYNAMICS OF A NOVEL LIVE BIOTHERAPEUTIC PRODUCT (LBP) IN HEALTHY ADULTS
Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S65–S66, https://doi.org/10.1093/ibd/izac015.106
Published: 22 January 2022
